EU approves medication that quenches urge to drink alcohol

The European Union has given the green light for the sale of a medication that will help quench the urge for alcoholics to drink, the companies behind the new treatment said Thursday.

Selincro, developed by Finland's Biotie Therapies, reduces "alcohol consumption by approximately 60 percent" or about a bottle of wine a day after six months, Danish drugmaker Lundbeck said.

With the go-ahead from the European Commission, Lundbeck, which will manufacture the medication, said it expects to launch Selincro by the middle of this year.

Selincro is mainly aimed at reducing in adults who drink heavily—consuming up to six drinks a day— but who do not suffer from withdrawal symptoms or need detoxification.

"Selincro is thought to reduce the reinforcing , and thereby reduces the urge to drink alcohol," Lundbeck said.

Lundbeck said is a world-wide problem, especially in Europe where it said more than 14 million people are dependent on alcohol.


Explore further

Herbal drug reduces the effects of alcohol

(c) 2013 AFP

Citation: EU approves medication that quenches urge to drink alcohol (2013, February 28) retrieved 19 June 2019 from https://medicalxpress.com/news/2013-02-eu-medication-quenches-urge-alcohol.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more